Sort
64,565 grants matching “drug discovery”
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,195,189Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2021 · TR
Developing Teixobactin for Respiratory Infections
$1,195,129Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R01 · FY2022 · AI
MR^3: Development of a Molecular Rotational Resonance Ratiometer
$1,194,805Steve Shipman · Brightspec, Inc. · R44 · FY2025 · GM
Center of Research Translation on the Osteoimmunology of Bone Infection
$1,194,792Edward M Schwarz · University Of Rochester · P50 · FY2017 · AR
Screening Core
$1,194,768James Robert Bostwick · University Of Alabama At Birmingham · U19 · FY2014 · AI
Structural characterization of OM proteins from Gram-negative pathogens
$1,194,758Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
CENTER FOR DEVELOPMENT OF ANTI-SPERM CONTRACEPTIVES
$1,194,716University Of California Davis · U54 · FY2004 · HD
Chimeric anti-Methamphetamine Monoclonal Antibody for Treating Stimulant Toxicity
$1,194,659R. Barry Holtz · Intervexion Therapeutics, Llc · RC2 · FY2009 · DA
Preclinical Development of HIV-1 Vif Antagonists
$1,194,404Mario Stevenson · University Of Miami School Of Medicine · P01 · FY2015 · MH
DON in Pediatric Cerebral Malaria: A Phase I / II Dose-Escalation Safety Study
$1,194,173Douglas Postels · Children'S Research Institute · U01 · FY2022 · AI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors
$1,194,113James C Sacchettini · Texas A&M University · U01 · FY2012 · GM
Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugates
$1,193,998Deborah T Hung · Broad Institute, Inc. · U19 · FY2022 · AI
Discovery of Novel Drugs for Alzheimer's Disease
$1,193,933University Of North Texas Hlth Sci Ctr · P01 · FY2005 · AG
Innovative Approaches for Cocaine Pharmacotherapy
$1,193,877Helen M Pettinati · University Of Pennsylvania · P50 · FY2006 · DA
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
$1,193,602Linda J Van Eldik · University Of Kentucky · R01 · FY2021 · AG
Dartmouth Lung Biology Center for Molecular, Cellular and Translational Research
$1,193,164Bruce A. Stanton · Dartmouth College · P30 · FY2015 · GM
Use of Artificial Intelligence/Machine Learning (AI/ML) to Enhance the STEP Pediatric Excipient Database
$1,193,090Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · AI
Genetics of Kidney Transplantiaion
$1,192,933Pui-Yan Kwok · Scripps Research Institute, The · U19 · FY2006 · AI
Screening and development of anti-Ebola entry inhibitors
$1,192,567Lijun Rong · University Of Illinois At Chicago · U01 · FY2009 · AI
Microenvironmental control of progenitors in organ dysfunction and repair
$1,192,208Jay W Schneider · Ut Southwestern Medical Center · U01 · FY2011 · HL
Small Molecule Therapeutics for Botullinum Neurotoxin A
$1,191,800Tobin J Dickerson · Scripps Research Institute, The · U01 · FY2010 · AI
Adenosine Receptor Agonists as an Immunotherapy for Biodefense
$1,191,560Peter B Ernst · University Of Virginia · U01 · FY2008 · AI
Discovery of Natural Products and Natural Product-Like Inhibitors
$1,191,299Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Nuclear and Glial Dysfunction in Neurodegeneration
$1,191,282Jeffrey D Rothstein · Johns Hopkins University · R35 · FY2024 · NS
CCR Office of Training and Education
$1,190,961Thomas A Misteli · Division Of Basic Sciences - Nci · ZIJ · FY2020 · CA